Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1059-1066
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1059
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1059
Figure 1 Flowchart of the study participants.
ITT: Intention-to-treat; PP: Per-protocol; H. pylori: Helicobacter pylori.
Figure 2 Helicobacter pylori eradication rates of second-line bismuth-based quadruple therapy according to years (P = 0.
01).
- Citation: Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Kim HK, Lee YD. Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes. World J Gastroenterol 2017; 23(6): 1059-1066
- URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1059.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i6.1059